𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

✍ Scribed by Hampel, Harald; Frank, Richard; Broich, Karl; Teipel, Stefan J.; Katz, Russell G.; Hardy, John; Herholz, Karl; Bokde, Arun L. W.; Jessen, Frank; Hoessler, Yvonne C.

Book ID
109951048
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
547 KB
Volume
9
Category
Article
ISSN
1474-1776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biomarkers for apoptosis in Alzheimer's
Biomarkers for apoptosis in Alzheimer's disease
✍ Maria Ankarcrona; Bengt Winblad πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract Alzheimer's disease (AD) affects millions of people worldwide and the number of AD cases will increase with increased life expectancy. Today there is no cure for this devastating and always lethal disease and therefore it is of great interest for patients, relatives and societies to fin

Structural MRI biomarkers for preclinica
Structural MRI biomarkers for preclinical and mild Alzheimer's disease
✍ Christine Fennema-Notestine; Donald J. Hagler Jr.; Linda K. McEvoy; Adam S. Flei πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 535 KB

## Abstract Noninvasive MRI biomarkers for Alzheimer's disease (AD) may enable earlier clinical diagnosis and the monitoring of therapeutic effectiveness. To assess potential neuroimaging biomarkers, the Alzheimer's Disease Neuroimaging Initiative is following normal controls (NC) and individuals w